331 related articles for article (PubMed ID: 11263929)
21. [Periodic examination of families with hereditary nonpolyposis colorectal carcinoma in The Netherlands: a study of 41 families].
Vasen HF
Ned Tijdschr Geneeskd; 1994 Jan; 138(2):77-81. PubMed ID: 8107907
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic surveillance for hereditary non-polyposis colorectal cancer (HNPCC) family members in a Southern Italian region.
Esposito I; de Bellis M; de Leone A; Rossi GB; Selvaggi F; Di Maio M; Musto D; Tracey MC; Marone P; Esposito P; Tempesta A; Riegler G
Dig Liver Dis; 2010 Oct; 42(10):698-703. PubMed ID: 20382092
[TBL] [Abstract][Full Text] [Related]
23. The tumor spectrum in HNPCC.
Watson P; Lynch HT
Anticancer Res; 1994; 14(4B):1635-9. PubMed ID: 7979199
[TBL] [Abstract][Full Text] [Related]
24. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
Möslein G
Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
[TBL] [Abstract][Full Text] [Related]
25. Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer.
Bermejo JL; Eng C; Hemminki K
Gastroenterology; 2005 Dec; 129(6):1889-99. PubMed ID: 16344057
[TBL] [Abstract][Full Text] [Related]
26. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
27. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
[TBL] [Abstract][Full Text] [Related]
28. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
29. Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review.
Johnson PM; Gallinger S; McLeod RS
Dis Colon Rectum; 2006 Jan; 49(1):80-93; discussion 94-5. PubMed ID: 16284887
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
[TBL] [Abstract][Full Text] [Related]
31. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
[TBL] [Abstract][Full Text] [Related]
32. Second primary extracolonic cancers in Japanese hereditary nonpolyposis colorectal cancer.
Tomoda H; Baba H; Taketomi A; Kohnoe S; Seo Y; Saito T
Oncol Rep; 1998; 5(1):143-5. PubMed ID: 9458310
[TBL] [Abstract][Full Text] [Related]
33. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.
Keller M; Jost R; Haunstetter CM; Sattel H; Schroeter C; Bertsch U; Cremer F; Kienle P; Tariverdian M; Kloor M; Gebert J; Brechtel A
Clin Genet; 2008 Nov; 74(5):414-24. PubMed ID: 18954412
[TBL] [Abstract][Full Text] [Related]
34. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families.
Auranen A; Joutsiniemi T
Acta Obstet Gynecol Scand; 2011 May; 90(5):437-44. PubMed ID: 21306348
[TBL] [Abstract][Full Text] [Related]
36. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
[TBL] [Abstract][Full Text] [Related]
37. Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database.
Maul JS; Warner NR; Kuwada SK; Burt RW; Cannon-Albright LA
Am J Gastroenterol; 2006 Jul; 101(7):1591-6. PubMed ID: 16863565
[TBL] [Abstract][Full Text] [Related]
38. [Families at risk of colon cancer II. Hereditary nonpolyposis colorectal carcinoma].
Hlavatý T; Lukác L; Duris I
Vnitr Lek; 2004 Aug; 50(8):606-14. PubMed ID: 15521204
[TBL] [Abstract][Full Text] [Related]
39. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group.
Gruber SB; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):411-7. PubMed ID: 8781735
[TBL] [Abstract][Full Text] [Related]
40. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
